Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Galderma Group AG is a global dermatology company specializing in the research, development, and marketing of medical solutions in skin health. The company operates in the pharmaceuticals, medical devices, and consumer products segments, offering treatments for conditions like acne, rosacea, psoriasis, and other dermatological ailments. Founded in 1981 and headquartered in Lausanne, Switzerland, Galderma leverages an extensive global network to distribute its products across various regions. The company's strategic focus on dermatology enables it to maintain a robust portfolio of targeted therapies and skincare solutions that address both medical and aesthetic needs.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Galderma Group AGEli Lilly
Last price
CHF 191.95$1,417.54
Currency
CHF
USD
CHF 45B$1.3T
63.7046.01
CHF 3.01$30.81
-0.110.45
CHF 0.35$6.69
0.18%0.49%
Sector
HealthHealth
Employees
7,67650,000
Ticker
Fr. GALD$LLY
Primary listing
XSWXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in Fr.GALD or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.